It has been over 20 years since we partnered with you to introduce the first SPECT/CT system. When we set out to help make SPECT/CT the essential clinical tool we believed it could be, we perceived only a glimmer of its potential. Today, we continue to be in awe as we watch you use this technology every day to better diagnose your patients and to further your own clinical research.
As we enter the third decade of this partnership, we are excited to introduce the third generation of the breakthrough CZT-based NM/CT 870 CZT that can now image at both the low and medium energy peaks.
Of course, the 800 Series is more than just NM/CT 870 CZT. It is a full family of five nuclear medicine systems that puts into practice everything we’ve learned over the course of 20+ years by bringing the latest in SPECT/CT advancements to a wider range of clinical environments. In addition to NM/CT 870 CZT, there is the digital-ready NM/CT 870 DR and the SPECT-only NM 830 and two eight-slice CT hybrids. With NM/CT 850, you’ll find a low-dose CT for nuclear medicine hybrid imaging that delivers high specificity for localization and attenuation correction, while NM/CT 860 also provides diagnostic CT capabilities. We strategically paired these two systems with CT technology that makes state-of-the-art CT performance accessible to practices with emerging or more routine hybrid needs.